Plasma tenascin-C level as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy

被引：0
|
作者：
Kitaoka, H. [1 ]
Kubo, T. [1 ]
Baba, Y. [1 ]
Yamasaki, N. [1 ]
Matsumura, Y. [1 ]
Furuno, T. [1 ]
Doi, Y. [1 ]
机构：
[1] Kochi Med Sch, Kochi, Japan
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：592 / 592
页数：1
相关论文
共 50 条
  • [31] Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?
    Kotby, Alyaa A.
    Aziz, ManalM. Abdel
    El Guindy, Waleed M.
    Moneer, Amira N.
    INTERNATIONAL JOURNAL OF PEDIATRICS, 2013, 2013
  • [32] Value of plasma renin activity as a prognostic biomarker in patients with heart failure
    Kim, JHJae Hee
    Jang, S. Y.
    Bae, M. H.
    Lee, J. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    Park, S. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 234 - 234
  • [33] Pressure Overload-induced Right Ventricular Failure is Associated with Re-expression of Myocardial Tenascin-C and Elevated Plasma Tenascin-C Levels
    Hessel, Marleen
    Steendijk, Paul
    den Adel, Brigit
    Schutte, Cindy
    van der Laarse, Arnoud
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2009, 24 (3-4) : 201 - 210
  • [34] Heart failure development predictors at patients with hypertrophic cardiomyopathy
    Khodjaeva, E. M.
    Ibadov, R. A.
    Khalikulov, K. H.
    Mansurov, A. A.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S111 - S111
  • [35] Prediction of worsening heart failure in patients with hypertrophic cardiomyopathy using plasma proteomics profiling
    Lumish, H.
    Liang, L. W.
    Hasegawa, K.
    Maurer, M.
    Tower-Rader, A.
    Fifer, M. A.
    Reilly, M. P.
    Shimada, Y. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1723 - 1723
  • [36] Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
    Mekhaimar, Menatalla
    Al Mohannadi, Moza
    Dargham, Soha
    Al Suwaidi, Jassim
    Jneid, Hani
    Khalil, Charbel Abi
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [37] Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy
    Kawasaki, T
    Azuma, A
    Sakatani, T
    Hadase, M
    Kamitani, T
    Kawasaki, S
    Kuribayashi, T
    Sugihara, H
    JOURNAL OF ELECTROCARDIOLOGY, 2003, 36 (04) : 333 - 338
  • [38] Influence of carvedilol treatment on plasma concentration of tenascin C in patients with postinfarction heart failure
    Astvatsatrian, AV
    Adamian, KG
    Vardanian, SI
    Chilingarian, AL
    Astvatsatrian, TR
    EUROPEAN HEART JOURNAL, 2001, 22 : 292 - 292
  • [39] Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy
    Zhu, Ling
    Wang, Jizheng
    Wang, Yilu
    Jia, Lei
    Sun, Kai
    Wang, Hu
    Zou, Yubao
    Tian, Tao
    Liu, Yan
    Zou, Juan
    Hui, Rutai
    Yuan, Zuyi
    Song, Lei
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (10) : 1252 - 1258
  • [40] Plasma large tenascin-C spliced variant as a possible biomarker for the prediction of hepatic recurrence in colorectal cancer
    Takeda, Akihiko
    Otani, Yoshihide
    Hirooka, Eiji
    Okada, Katsuya
    Torii, Takahiro
    Shinozuka, Nozomi
    Koyama, Isamu
    SURGERY, 2007, 141 (01) : 124 - 125
12345